Alzheimer's disease (AD) is described as cognitive and memory impairments with a sex-
related epidemiological profile, affecting two times more women than men. There is …

Magnetic resonance imaging (MRI) and positron emission tomography (PET) have made
great strides in the diagnosis and our understanding of Alzheimer's Disease (AD). Despite …

Alzheimer's disease (AD) is a progressive degenerative brain disease and the primary
cause of dementia. At an early stage, AD is generally characterized by short-term memory …

Background Alzheimer's disease (AD) is a progressive degenerative disorder that currently
remains extremely disabling. Recent work has shown that deep brain stimulation (DBS) has …

The understanding of the natural history of Alzheimer's disease (AD) and temporal
trajectories of in vivo molecular mechanisms requires longitudinal approaches. A behavioral …

Oxidative stress due to hypobaric hypoxia at extreme altitudes causes severe neuronal
damage and irreversible cognitive loss. Owing to contraindications of current drug therapies …

Selective serotonin reuptake inhibitors (SSRIs) have been reported to increase cognitive
performance in some clinical studies of Alzheimer's disease (AD). However, there is a lack of …

Alzheimer's disease (AD) is the most common cause of dementia globally. AD is a
progressive neurodegenerative disorder, eventually manifesting as severe cognitive …

Xanthoceras sorbifolia, a traditional Chinese folk medicine with anti-inflammatory effects,
has been used for a long time in China, especially in the Inner Mongolian area for the …

Background Alzheimer's disease (AD) is the most common type of dementia and mainly
treated by drugs, while the therapeutic outcomes are very limited. This study aimed to …